Clinical Trials in Baltimore

Showing 2501-2520 of 20,142 trials

Safety and Effectiveness of the Globe® Pulsed Field System for Treating Patients With Symptomatic Paroxysmal or Persistent Atrial Fibrillation

NCT05462145

This study will evaluate the safety and effectiveness of the Globe® Pulsed Field System for treating patients with symptomatic paroxysmal or persistent atrial fibrillation (AF).

Paroxysmal Atrial FibrillationPersistent Atrial Fibrillation

Kardium Inc.549 participantsStarted Mar 2023

Birmingham, Alabama, United States • Jonesboro, Arkansas, United States • San Francisco, California, United States +15 more locations

COMPLETEDPhase 2/3< 1 mile

A Study to Evaluate the Efficacy and Safety of ABC008 for Inclusion Body Myositis

NCT05721573

A Phase II/III Randomized, Double-blind, Placebo-controlled, Multicenter Study to Determine the Efficacy and Safety of ABC008 in the Treatment of Subjects with Inclusion Body Myositis

Inclusion Body Myositis

Abcuro, Inc.272 participantsStarted Feb 2023

Phoenix, Arizona, United States • Irvine, California, United States • Los Angeles, California, United States +42 more locations

Safety and Effectiveness of the Globe® Pulsed Field System for Treating Patients With Symptomatic Paroxysmal or Persistent Atrial Fibrillation

A Study to Evaluate the Efficacy and Safety of ABC008 for Inclusion Body Myositis

Find Trials by Condition in Baltimore

A Study of mRNA-1345 Following a Primary Dose of a Licensed Protein Subunit Respiratory Syncytial Virus (RSV) Vaccine in Adult Participants ≥60 Years of Age

Prevention of Postpartum Hemorrhage With Tranexamic Acid

Optimal Pediatric Heart Transplant Immunosuppression With MicroRNAs

TVMR With the INNOVALVE System Trial - Early Feasibility Study

Randomized, Double-blind, Placebo-controlled, Crossover Study of Atrasentan in Subjects With IgA Nephropathy

Supporting Evidence-based Responses to Emotional Needs in Emphysema

TACE With or Without SBRT as Bridging Therapy for Pre-transplant HCC Patients

A Phase 1/2 Study to Evaluate CHM-2101, an Autologous Cadherin 17 Chimeric Antigen Receptor (CAR) T Cell Therapy

A Study in Patients Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab Study

Dose-finding Study of SAR443122 in Adult Participants With Ulcerative Colitis

Integrated Therapies for Alcohol Use in Alcohol-associated Liver Disease (ITAALD) Trial

Abbott Structural Heart Device Registry

Testing the Addition of the Anti-cancer Viral Therapy Telomelysin™ to Chemoradiation for Patients With Advanced Esophageal Cancer and Are Not Candidates for Surgery

A Study of Modakafusp Alfa Together With Daratumumab Adults With Relapsed or Refractory Multiple Myeloma

A Study of FX-909 in Patients With Advanced Solid Malignancies, Including Advanced Urothelial Carcinoma

A Study of Sacituzumab Govitecan Given at an Alternative Dose and Schedule in Participants With Advanced Triple-Negative Breast Cancer

A Clinical Trial of PRAX-562 in Subjects With Developmental and Epileptic Encephalopathies (DEE)

BCL2i CLAG-M in R/R Acute Myeloid Leukemia